Form 4 holding
Chief Executive Officer, Director
Cyclo Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 743,804
- Estimated value
- $528,101
- Report date
- 20 Oct 2023
- Price
- $0.7100
- Ownership
- Direct
N. Scott Fine - Chief Executive Officer, Director at Cyclo Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- CYTH
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by N. Scott Fine since 12 Sep 2025
Reported holdings for N. Scott Fine in Cyclo Therapeutics, Inc.
Form 4 holding
Chief Executive Officer, Director
Cyclo Therapeutics, Inc.
- Security class
- Warrant to Purchase Common Stock
- Shares / value
- 329,342
- Estimated value
- $41,168
- Report date
- 20 Oct 2023
- Price
- $0.1250
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Cyclo Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 266,354
- Estimated value
- Report date
- 03 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for N. Scott Fine in Cyclo Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.